ArticleCanadian journal of gastroenterology & hepatology2016

Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action.

Nicole A Tillie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.